CLINICAL_TRIALS
research
· 2025-12-17
Clinical Trial Update: Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study) [NA]
Summary
A clinical trial (PreVail-PH2) is currently recruiting to evaluate the Gradient Denervation System for pulmonary artery denervation in heart failure patients wi…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gradient Denervation Technologies | Conditions: Group 2 Pulmonary Hypertension, Heart Failure | NA | Status: RECRUITING